Evogene Ltd. (TLV:EVGN)

Evogene Revenue

In the year 2025, Evogene had annual revenue of $3.85M USD, down -30.91%. Evogene had revenue of $314.00K in the quarter ending December 31, 2025.

• Revenue: $3.85M
• Revenue Growth: -30.91%
• P/S Ratio: 1.91
• Revenue / Employee: $74.10K
• Employees: 52
• Market Cap: 23.52M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.85M	-1.72M	-30.91%
Dec 31, 2024	5.58M	2.60M	87.02%
Dec 31, 2023	2.98M	1.31M	78.03%
Dec 31, 2022	1.68M	745.00K	80.11%
Dec 31, 2021	930.00K	-110.00K	-10.58%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error